Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation

Abstract

Chronically intermittent hemodialysis for end-stage renal failure requires anticoagulation to prevent clotting in the extracorporeal circuit. Anticoagulation usually is performed by continuous infusion of unfractionated heparin or by bolus administration of low-molecular-weight heparin.[1][1] At our